Form4insider filings, from the source

SEC Form 5 · accession 0001388410-19-000005

PARALLAX HEALTH SCIENCES, INC. · PRLX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Calli Bucci
Officer — CFO · Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 15, 2019 · 6:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKAug 13, 2018M1,071,430$0.05A7,452,992D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
STOCK OPTIONS$0.25Oct 10, 2018A1,000,000ADec 31, 2018Dec 31, 2022COMMON STOCK1,000,0002,500,000D
STOCK OPTIONS$0.05Aug 13, 2018M1,071,430DAug 13, 2018Aug 13, 2018COMMON STOCK1,071,4301,428,570D
STOCK OPTIONS$0.05Aug 13, 2018F428,570DAug 13, 2018Aug 13, 2018COMMON STOCK428,5701,000,000D
PREFERRED STOCK (SERIES C)$0.12Sep 30, 2018A30,000ASep 30, 2018Sep 30, 2020COMMON STOCK1,250,0001,030,000D
WARRANTS$0.25Sep 30, 2018A15,000ASep 30, 2018Sep 30, 2021COMMON STOCK625,0001,045,000D

Explanation of responses